S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
NASDAQ:ACHC

Acadia Healthcare - ACHC Stock Forecast, Price & News

$82.63
+0.02 (+0.02%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$80.22
$82.80
50-Day Range
$63.69
$82.91
52-Week Range
$50.07
$83.63
Volume
408,420 shs
Average Volume
575,144 shs
Market Capitalization
$7.51 billion
P/E Ratio
27.09
Dividend Yield
N/A
Price Target
$81.89

Acadia Healthcare MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
0.9% Downside
$81.89 Price Target
Short Interest
Bearish
3.99% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.69
Upright™ Environmental Score
News Sentiment
0.38mentions of Acadia Healthcare in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$2.38 M Sold Last Quarter
Proj. Earnings Growth
7.03%
From $3.13 to $3.35 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.11 out of 5 stars

Medical Sector

647th out of 1,125 stocks

Specialty Outpatient Clinics, Not Elsewhere Classified Industry

1st out of 3 stocks

ACHC stock logo

About Acadia Healthcare (NASDAQ:ACHC) Stock

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or 24-hour observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and offer therapeutic placement for children and adolescents with emotional disorders. As of February 28, 2022, it operated a network of 228 behavioral healthcare facilities with approximately 10,500 beds. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on ACHC shares. UBS Group lifted their price objective on Acadia Healthcare from $82.00 to $90.00 and gave the stock a "buy" rating in a research report on Thursday, July 28th. Loop Capital started coverage on shares of Acadia Healthcare in a research report on Thursday, June 16th. They set a "hold" rating and a $72.00 price objective on the stock. BMO Capital Markets lifted their target price on shares of Acadia Healthcare from $67.00 to $82.00 in a research note on Friday, May 6th. Mizuho increased their price target on shares of Acadia Healthcare from $64.00 to $69.00 in a research note on Wednesday, May 4th. Finally, Jefferies Financial Group lifted their price objective on Acadia Healthcare from $85.00 to $95.00 in a research report on Thursday, July 28th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat, Acadia Healthcare currently has an average rating of "Moderate Buy" and a consensus target price of $81.89.

Acadia Healthcare Stock Up 0.0 %

NASDAQ:ACHC traded up $0.02 during mid-day trading on Monday, hitting $82.63. 408,420 shares of the company's stock were exchanged, compared to its average volume of 575,144. The company has a market cap of $7.51 billion, a PE ratio of 27.09, a P/E/G ratio of 2.12 and a beta of 1.30. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.17 and a quick ratio of 1.17. Acadia Healthcare has a one year low of $50.07 and a one year high of $83.63. The business has a fifty day moving average price of $73.79 and a 200 day moving average price of $67.99.

Acadia Healthcare (NASDAQ:ACHC - Get Rating) last released its earnings results on Wednesday, July 27th. The company reported $0.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.07. The firm had revenue of $651.72 million during the quarter, compared to analyst estimates of $650.80 million. Acadia Healthcare had a net margin of 11.32% and a return on equity of 10.34%. The business's revenue was up 11.9% on a year-over-year basis. During the same period last year, the business earned $0.71 earnings per share. Equities analysts predict that Acadia Healthcare will post 3.13 EPS for the current year.

Insiders Place Their Bets

In other news, EVP Christopher L. Howard sold 12,214 shares of the firm's stock in a transaction on Monday, August 8th. The stock was sold at an average price of $81.67, for a total transaction of $997,517.38. Following the completion of the transaction, the executive vice president now directly owns 149,147 shares in the company, valued at $12,180,835.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, EVP Christopher L. Howard sold 12,214 shares of the stock in a transaction dated Monday, August 8th. The shares were sold at an average price of $81.67, for a total transaction of $997,517.38. Following the sale, the executive vice president now directly owns 149,147 shares of the company's stock, valued at approximately $12,180,835.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP John S. Hollinsworth sold 10,780 shares of Acadia Healthcare stock in a transaction dated Thursday, August 4th. The stock was sold at an average price of $80.68, for a total transaction of $869,730.40. Following the completion of the transaction, the executive vice president now directly owns 80,559 shares of the company's stock, valued at $6,499,500.12. The disclosure for this sale can be found here. Over the last three months, insiders have sold 29,094 shares of company stock valued at $2,375,868. 1.90% of the stock is currently owned by corporate insiders.

Receive ACHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acadia Healthcare and its competitors with MarketBeat's FREE daily newsletter.

ACHC Stock News Headlines

Acadia Healthcare (NASDAQ:ACHC) Price Target Raised to $82.00
Acadia Healthcare (NASDAQ:ACHC) PT Raised to $90.00
See More Headlines
Receive ACHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acadia Healthcare and its competitors with MarketBeat's FREE daily newsletter.

ACHC Company Calendar

Last Earnings
7/27/2022
Today
8/15/2022
Next Earnings (Estimated)
10/27/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Specialty outpatient clinics, not elsewhere classified
Sub-Industry
Health Care Facilities
Sector
Medical
Current Symbol
NASDAQ:ACHC
CUSIP
00404A10
Employees
22,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$81.89
High Stock Price Forecast
$95.00
Low Stock Price Forecast
$69.00
Forecasted Upside/Downside
-0.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$190.63 million
Pretax Margin
15.12%

Debt

Sales & Book Value

Annual Sales
$2.31 billion
Cash Flow
$3.81 per share
Book Value
$27.99 per share

Miscellaneous

Free Float
89,115,000
Market Cap
$7.51 billion
Optionable
Optionable
Beta
1.30

Key Executives

  • Mr. David M. Duckworth (Age 42)
    Chief Financial Officer
    Comp: $1.71M
  • Mr. John S. Hollinsworth (Age 58)
    Exec. VP of Operations
    Comp: $1.59M
  • Mr. Christopher L. Howard (Age 55)
    Exec. VP, Gen. Counsel & Sec.
    Comp: $1.55M
  • Mr. Laurence L. Harrod (Age 65)
    Exec. VP of Fin.
    Comp: $1.92M
  • Mr. Christopher Howal Hunter (Age 54)
    CEO & Director
  • Gretchen Hommrich
    VP of Investor Relations
  • Dr. Anne Kelly B.S.N.
    Ed.D., Chief Quality & Compliance Officer
  • Mr. Andrew Honeybone
    Sr. VP of HR
  • Ms. Isa Diaz
    Sr. VP of Strategic Affairs
  • Dr. Michael Genovese J.D.
    M.D., Chief Medical Officer













ACHC Stock - Frequently Asked Questions

Should I buy or sell Acadia Healthcare stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Acadia Healthcare in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ACHC shares.
View ACHC analyst ratings
or view top-rated stocks.

What is Acadia Healthcare's stock price forecast for 2022?

5 Wall Street research analysts have issued twelve-month price targets for Acadia Healthcare's stock. Their ACHC share price forecasts range from $69.00 to $95.00. On average, they predict the company's stock price to reach $81.89 in the next twelve months. This suggests that the stock has a possible downside of 0.9%.
View analysts price targets for ACHC
or view top-rated stocks among Wall Street analysts.

How have ACHC shares performed in 2022?

Acadia Healthcare's stock was trading at $60.70 at the beginning of the year. Since then, ACHC stock has increased by 36.1% and is now trading at $82.63.
View the best growth stocks for 2022 here
.

When is Acadia Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our ACHC earnings forecast
.

How were Acadia Healthcare's earnings last quarter?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) issued its quarterly earnings data on Wednesday, July, 27th. The company reported $0.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.77 by $0.07. The business earned $651.72 million during the quarter, compared to analysts' expectations of $650.80 million. Acadia Healthcare had a net margin of 11.32% and a trailing twelve-month return on equity of 10.34%. Acadia Healthcare's quarterly revenue was up 11.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.71 EPS.

What guidance has Acadia Healthcare issued on next quarter's earnings?

Acadia Healthcare updated its FY 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share (EPS) guidance of $2.93-$3.18 for the period, compared to the consensus estimate of $3.01. The company issued revenue guidance of $2.56 billion-$2.60 billion, compared to the consensus revenue estimate of $2.59 billion.

What is Debra K. Osteen's approval rating as Acadia Healthcare's CEO?

41 employees have rated Acadia Healthcare Chief Executive Officer Debra K. Osteen on Glassdoor.com. Debra K. Osteen has an approval rating of 36% among the company's employees. This puts Debra K. Osteen in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Acadia Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acadia Healthcare investors own include Chipotle Mexican Grill (CMG), Endologix (ELGX), American Airlines Group (AAL), Archer-Daniels-Midland (ADM), Athabasca Oil (ATH), Aegean Marine Petroleum Network (ANW), Broadcom (AVGO), Exxon Mobil (XOM) and Colfax (CFX).

What is Acadia Healthcare's stock symbol?

Acadia Healthcare trades on the NASDAQ under the ticker symbol "ACHC."

Who are Acadia Healthcare's major shareholders?

Acadia Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional investors include JPMorgan Chase & Co. (4.43%), William Blair Investment Management LLC (4.15%), FMR LLC (2.69%), Stephens Investment Management Group LLC (1.76%), Loomis Sayles & Co. L P (1.41%) and Aristotle Capital Boston LLC (1.24%). Insiders that own company stock include Christopher L Howard, David M Duckworth, Debra K Osteen, John S Hollinsworth, Reeve B Waud and William M Petrie.
View institutional ownership trends
.

How do I buy shares of Acadia Healthcare?

Shares of ACHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Acadia Healthcare's stock price today?

One share of ACHC stock can currently be purchased for approximately $82.63.

How much money does Acadia Healthcare make?

Acadia Healthcare (NASDAQ:ACHC) has a market capitalization of $7.51 billion and generates $2.31 billion in revenue each year. The company earns $190.63 million in net income (profit) each year or $3.05 on an earnings per share basis.

How many employees does Acadia Healthcare have?

The company employs 22,500 workers across the globe.

How can I contact Acadia Healthcare?

Acadia Healthcare's mailing address is 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067. The official website for the company is www.acadiahealthcare.com. The company can be reached via phone at (615) 861-6000 or via fax at 615-261-9685.

This page (NASDAQ:ACHC) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.